Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Discuss long-term treatment plans with your PlexusDx provider to determine whether ongoing therapy or a structured transition plan makes sense for your goals
GLP-1 Plus by Advanced BioNutritionals: 2025 DHB Breakthrough Ignites Interest in Non-Injection Hunger and Weight Trends Public interest in GLP-1 alternatives has surged in 2025, fueled by the search for effective, non-injection options that align with evolving wellness goals
Its compounded options make treatment affordable without insurance or membership fees, and pricing stays transparent
Ozempic (semaglutide) is also used off-label for weight management
Safety of selective androgen receptor modulators
The liver-targeted THR agonist resmetirom (MGL-3196) demonstrated significant reductions in hepatic lipid fraction and fibrosis, as well as plasma lipid and enzyme levels in patients with MASH, without affecting blood glucose or insulin levels (NCT02912260)
US$ 28.33
US$ 22.39
US$ 20.57
US$ 28.37
